These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 134003)

  • 1. Degree of sulfation in mucopolysaccharide sulfates in normal and stone-forming urines.
    Foye WO; Hong HS; Kim CM; Prien EL
    Invest Urol; 1976 Jul; 14(1):33-7. PubMed ID: 134003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A methodology for the characterization of urinary glycosaminoglycans.
    Thorne ID; Resnick MI
    J Urol; 1984 May; 131(5):995-9. PubMed ID: 6423842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.
    Shum DK; Gohel MD
    Clin Sci (Lond); 1993 Jul; 85(1):33-9. PubMed ID: 8149691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Observation on urinary glycosaminoglycan excretion in patients with urinary calculus in relation to the nature of organic matrix of calculi].
    Baba S; Nakazawa K; Odajima K; Fujioka T; Nakamura H
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):608-15. PubMed ID: 6413740
    [No Abstract]   [Full Text] [Related]  

  • 6. Anomalous structure of urinary chondroitin sulfate from cancer patients. A potential new marker for diagnosis of neoplasias.
    Dietrich CP; Martins JR; Sampaio LO; Nader HB
    Lab Invest; 1993 Apr; 68(4):439-45. PubMed ID: 8479152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Composition and degree of sulfation of glycosaminoglycans from tissues of different animal species: heterogeneity and tissue specificity of heparan sulfates].
    Zimina NP; Dmitriev IP; Rykova VI
    Biokhimiia; 1987 Jun; 52(6):984-90. PubMed ID: 2959327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
    Sallis JD; Lumley MF
    Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary sulfated glycosaminoglycan insufficiency and chondroitin sulfate supplement in urolithiasis.
    Dissayabutra T; Kalpongnukul N; Chindaphan K; Srisa-Art M; Ungjaroenwathana W; Kaewwongse M; Iampenkhae K; Tosukhowong P
    PLoS One; 2019; 14(3):e0213180. PubMed ID: 30845174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composition of urinary glycosaminoglycans in a patient with juvenile hyaline fibromatosis.
    Leta G; Abad ED; Martins RC; Dellias JM; Silva LC
    Clin Chim Acta; 2004 Mar; 341(1-2):205-7. PubMed ID: 14967178
    [No Abstract]   [Full Text] [Related]  

  • 11. Noninvasive diagnosis of tubular damage by the use of the urinary chondroitin-4-sulfate/heparan sulfate ratio.
    Lubec G; Kircher S; Grillenberger A
    Padiatr Padol; 1986; 21(4):357-61. PubMed ID: 2951642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophoresis separation of glycosaminoglycans on nitrocellulose membranes.
    Volpi N
    Anal Biochem; 1996 Aug; 240(1):114-8. PubMed ID: 8811886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of urinary stone disease and extracorporeal shockwave lithotripsy on excretion of glycosaminoglycans.
    Erkurt B; Ilker Y; Budak Y; Ozveren B; Türkeri L; Akdas A
    J Endourol; 1999 Oct; 13(8):553-7. PubMed ID: 10597124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of glycosaminoglycans in normal and stone forming subjects.
    Michelacci YM; Glashan RQ; Schor N
    Kidney Int; 1989 Dec; 36(6):1022-8. PubMed ID: 2601252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratan and herparan sulfaturia: glucosamine-6-sulfate deficiency.
    Matalon R; Wappner R; Deanching M; Brandt IK; Horwitz A
    Ann Clin Lab Sci; 1982; 12(3):234-8. PubMed ID: 6212020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary acid mucopolysaccharides in multiple sulfatase deficiency (mucosulfatidosis).
    Eto Y; Numaguchi S; Handa T
    Eur J Pediatr; 1979 Nov; 132(3):207-11. PubMed ID: 159821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.
    Erickson DR; Ordille S; Martin A; Bhavanandan VP
    J Urol; 1997 Jan; 157(1):61-4. PubMed ID: 8976216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis.
    Volpi N
    Anal Biochem; 1999 Sep; 273(2):229-39. PubMed ID: 10469494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive diagnosis of tubular damage by the use of urinary chondroitin-4-sulfate/heparan sulfate ratio.
    Lubec G; Kircher S
    Nephron; 1986; 42(4):340. PubMed ID: 2938022
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary glycosaminoglycan excretion as a biochemical marker in patients with bladder carcinoma.
    Hennessey PT; Hurst RE; Hemstreet GP; Cutter G
    Cancer Res; 1981 Oct; 41(10):3868-73. PubMed ID: 6793229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.